Copper-67 from Iotron Medical in collaboration with CIIC
Copper-67 fromIotron Medical in collaboration with CIIC

How do Iotron and CIIC            make Copper-67?

The use of copper-67 radioisotope has been severely limited up to this point because it has traditionally been difficult to obtain, was often not very pure, and also very expensive.  Iotron are working with parners to commercialize a new production method based on enriched zinc-68 targets and a compact electron beam accelerator.

A patented sublimation process separates the copper-67 from the target which also facilitates rapid and efficient target recycling.  The resulting copper-67 has high specific activity and low chemical and radiochemical impurity levels.

The four granted US patents are provided below (Europe and Japan patents also granted):

US Patent 8526561
US8526561.pdf
Adobe Acrobat document [753.0 KB]
US Patent 9312037
US9312037.pdf
Adobe Acrobat document [875.0 KB]
US Patent 10134497
US10134497.pdf
Adobe Acrobat document [1.2 MB]
US Patent 11049628
US11049628.pdf
Adobe Acrobat document [898.6 KB]

Iotron Medical, a spin-out business of Iotron Industries - providing innovative solutions using electron beam technology for more than 25 years

Canadian Isotope Innovations, operating the most capable radioisotope electron accelerator in North America today

Contact us today!

If you have any queries or wish to contact us:

 

For partnering opportunities:
enquiries@copper67.com

 

To buy radioisotope:

sales@copper67.com

 

 

Print Print | Sitemap
© Iotron Medical Inc 2021